Islamabad: Pakistan’s pharmaceutical sector has reached an impressive milestone, as eight local companies have garnered international acclaim for producing medicines that meet global standards. This achievement has been facilitated by the efforts of the Special Investment Facilitation Council (SIFC), which has played a crucial role in elevating the industry’s stature on the world stage.

The commendable progress is largely attributed to the stringent quality controls implemented by drug testing laboratories in Faisalabad, Lahore, and Gujranwala. These facilities have been pivotal in ensuring that the pharmaceutical products not only meet but exceed international quality benchmarks.

The certifications awarded by various global organizations have significantly bolstered the credibility of Pakistan’s pharmaceutical products in the international market. This newfound global recognition is proving to be immensely beneficial for the country’s economy, with positive ramifications for both national economic growth and export figures.

The success of these pharmaceutical entities underscores the potential of Pakistan’s industries to compete on a global scale, driving economic development and enhancing the country’s export portfolio. The support from the SIFC highlights the importance of strategic facilitation and investment in achieving such international milestones.